Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in ...
Dr. Marty Makary is largely sidestepping Senate questions about his plans to lead the Food and Drug Administration.
The Food and Drug Administration (FDA) has approved Stoboclo® (denosumab-bmwo), a biosimilar to Prolia® (denosumab), and Osenvelt® (denosumab-bmwo), a ...
FDA staffers tell CR how the suspension of their discretionary spending is threatening the safety of the American food supply ...
The FDA is expected to decide on treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine.
The Food and Drug Administration (FDA ... active-controlled phase 3 trial (ClinicalTrials.gov Identifier: NCT04757376) that compared denosumab-bmwo to the reference product (Prolia) in ...
Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP ...
The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).
The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...
The FDA has approved Miudella® (copper intrauterine system) for the prevention of pregnancy in females of reproductive potential for up to 3 years.
The state’s insurance regulator has demanded detailed information about patients and their medications, raising privacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback